2021•JACC Heart FailureOpen access

The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials

Silvia Oghina, Wulfran Bougouin, Mélanie Bézard, Mounira Kharoubi, Michel Komajda, Alain Cohen‐Solal, Alexandre Mebazaa, Thibaud Damy, Diane Bodez

Open full text 89 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 89 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cardiac amyloidosis, Heart failure with preserved ejection fraction, Medicine, Ejection fraction, Cardiology, Heart failure, Internal medicine, Amyloidosis

Back to paper search Browse research topics Original source

The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials — Research Paper | ScholarLens